Treatment of Lateralisation and Subluxation of the Hip in Cerebral Palsy with Botulinum Toxin A: Preliminary Results Based on the Analysis of Migration Percentage Data

Neuropediatrics

Volumn 35, Issue 1, 2004, Pages 6-9

  Placzek, Richard ^a   Deuretzbacher, G ^a   Meiss, A L ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adductor spasm; Botulinum toxin A (Btx A); Cerebral palsy; Hip lateralisation subluxation

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HIP DISEASE; HUMAN; MUSCLE SPASM; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; RANK SUM TEST; REIMER MIGRATION PERCENTAGE; SUBLUXATION; TREATMENT OUTCOME;

BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HIP CONTRACTURE; HUMANS; NEUROMUSCULAR AGENTS;

EID: 1542724586     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43549     Document Type: Article

References (17)

1. Boyd RN, Britton TC, Robinson RO, Borzyskowski M. Transient urinary incontinence after Botulinum A toxin. Lancet 1996; 348: 481-482
2. Boyd RN, Dobson F, Parrot J, Love S, Oates J, Larson A, Burchall G, Chondros P, Carlin J, Nattrass G, Graham HK. The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomised controlled trial. Eur J Neurol 2001; 8 (Suppl 5):109-119
3. Corry IS, Cosgrove AP, Walsh EG et al. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997; 39: 185-193
4. Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan JM, Fontan D, Pontallier JR. Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children. Rev Chir Orthop Reparatrice Appar Mot 2002; 88: 279-285
5. Fehlings D, Rang M, Glazier J et al. An evaluation of botulinum toxin A injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatric 2000; 137: 331-337
6. Garner CG, Straube A, Witt TN, Gasser T, Oertel WH. Time course of distant effects of local injections of botulinum toxin. Mov Disord 1993; 8: 33-37
7. Heinen F, Wissel J, Mall V, Philipsen A, Leititis JU, Bernius P, Stücker R, Korinthenberg R. Interventionelle Neuropädiatrie. Behandlungsmöglichkeiten mit Botulinumtoxin A. In: Boltshauser E, Schmitt B, Steinlin M (Eds), Aktuelle Neuropädiatrie 1996. Nürnberg: Novartis Pharma Verlag, 1996: 251-259
8. Kirschner J, Berweck S, Korinthenberg R, Heinen F. Behandlung mit Botulinumtoxin. Dt Ärztebl 2001; 98: A3375-3379
9. Koman LA, Mooney 3rd JF, Smith BP et al. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy. A randomised, double blind, placebo-controlled trial. J Pediatr Orthop 2000; 20: 108-115
10. Konstanzer A, Ceballos-Baumann AO, Dressnandt J, Conrad B. Lokale Injektionsbehandlung mit Botulinumtoxin A bei schwerer Arm- und Beinspastik. Nervenarzt 1993; 64: 517-523
11. Mall V, Heinen F, Kirschner J. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure. J Child Neurol 2000; 15: 214-217
12. Philipsen A, Heinen F, Scheidt CE, Korinthenberg R. Psychosoziale Veränderungen unter Langzeitbehandlung mit Botulinumtoxin A. In: Boltshauser E, Schmitt B, Steinlin M (Eds.) Aktuelle Neuropädiatrie 1996. Nürnberg: Novartis Pharma Verlag, 1996: 260-263
13. Placzek R, Meiss L. Behandlung mit Botulinumtoxin A innerhalb und außerhalb der Standardindikationen. Osteologie 2001; 10 (Suppl 2): 69
14. Reimers J. The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy. Copenhagen, Århus, Odense: FADLs Forlag, 1980
15. Scrutton D, Baird G. Surveillance measures of the hip of children with bilateral cerebral palsy. Arch Dis Child 1997; 76: 381-384
16. Ubhi T, Bhakta BB, Ives HL et al. Randomized double-blind, placebo-controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child 2000; 83: 481-487
17. Wissel J, Heinen F, Schenkel A et al. Botulinum toxin A in the management of spasticity gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment. Neuropediatrics 1999, 30: 120-124